Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence

NCT01078792 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.

NCT NCT01078792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01078792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence
Lead sponsor
Hillel Yaffe Medical Center
Phase
Observational
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disease exacerbation, prothrombin fragments, pulmonary disease, chronic obstructive, pulmonary embolism